Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain-containing protein 42 (ZBTB42) is a nuclear protein belonging to the C2H2 zinc finger protein family, possessing a BTB (pox virus and zinc finger, or POZ) domain at the N-terminus and four C-terminal zinc finger domains. It functions as a DNA-binding transcriptional repressor and is presumed to recruit chromatin remodeling multiprotein complexes. ZBTB42 is primarily expressed in the nuclei of skeletal muscle cells and is involved in skeletal muscle development; disruption of ZBTB42 can lead to abnormal muscle formation and has been associated with lethal congenital contracture syndrome, a severe inherited muscle-wasting disorder[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain-containing protein 42 (ZBTB42).